Realm Therapeutics PLC (LSE:RLM) - Share price - Overview

Stock Report

Realm Therapeutics PLC RLM

Last Price
GBX38.50

Day Change
0.00|0.00%

As of 21/06/2018
14:41:54 BST | GBX
Minimum 15 Minutes Delay.

Last Close38.50p
Day Range37.51 - 37.51
Mkt Cap44.88Mil
52-Wk Range27.41 - 49.00
Yield %-
ISINGB00B3XBCR18
Volume3,631
P/E-240.63
P/S22.65
P/CF-2.64

Share Price

Total Returns 21/06/2018

 Chg (%)  
More ...
Realm Therapeutics PLC-1.28 
FTSE 100 TR GBP-3.52
 
Financials
201520162017
More ...
Income Statement
Turnover1.230.871.12
Operating Profit-5.19-7.31-10.69
Net Profit-5.24-7.33-10.53
Reported EPS-0.10-0.15-0.16
Balance Sheet
Current Assets20.2521.7934.54
Non Current Assets4.530.460.57
Total Assets24.7822.2535.11
Current Liabilities5.443.202.91
Total Liabilities5.443.202.91
Total Equity19.3419.0532.20
Cash Flow
Operating Cash Flow-3.43-4.94-9.50
Net Change in Cash-5.406.01-11.90
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
10/10/2017PurchaseMr. John Alexander Martin29.00148,11542,953.00
10/10/2017PurchaseMr. Charles Alexander Evan Spicer29.0086,20725,000.00

Company Profile

Realm Therapeutics PLC is a biopharmaceutical company which focuses on leveraging its proprietary immunomodulatory technology to protect and improve the health of adults and children.

Sector

Biotechnology

Index

Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-33.21
Op Mrgn-9.54
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Executive OfficerMr. John Alexander Martin
Non-Executive Director, ChairmanMr. Charles Alexander Evan Spicer
Executive Director, Grp Fin Dir, Com Sec and Chf Opp OffcrMarella Thorell
Non-Executive DirectorMr Joseph William Birkett
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.